BRAD ANDREW GREENBAUM
Allopathic & Osteopathic Physicians|Pediatrics NASHVILLE, TN NPI 1801889274
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics TN PFIZER INC. All categories
General Payments — all program years on this page
$1,436.64
- Category: General Payments
- Program years: PY2018–2024
- Record count: 92
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $197.37 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $197.37 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $65.10 | 3 |
| Verrica Pharmaceuticals Inc. | $49.11 | 2 |
| Merck Sharp & Dohme Corporation | $45.33 | 2 |
| GlaxoSmithKline, LLC. | $22.38 | 1 |
| Cranial Technologies, Inc | $15.45 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1082234760 | Cranial Technologies, Inc | $15.45 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115881947 | GlaxoSmithKline, LLC. | $22.38 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118381318 | Verrica Pharmaceuticals Inc. | $24.23 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118381320 | Verrica Pharmaceuticals Inc. | $24.88 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131282144 | PFIZER INC. | $18.68 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131681499 | PFIZER INC. | $29.13 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131892918 | PFIZER INC. | $17.29 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141565303 | Merck Sharp & Dohme LLC | $20.36 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141565305 | Merck Sharp & Dohme LLC | $24.97 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.